dapagliflozinmetformin sold brand name xigduo xr amongst others fixeddose combination antidiabetic medication used adjunct diet exercise improve glycemic control adults type combination dapagliflozin taken dapagliflozinmetformin approved use european union january united states february australia july lessen risk developing ketoacidosis serious condition body produces high levels blood acids called ketones surgery fda approved changes prescribing information inhibitor diabetes medicines recommend stopped temporarily scheduled surgery canagliflozin dapagliflozin empagliflozin stopped least three days ertugliflozin stopped least four days scheduled symptoms ketoacidosis include nausea vomiting abdominal pain tiredness trouble potential interaction dapagliflozin lithium concomitant causing lto reduction serum lithium levels bulletined drug article relating gastrointestinal system stub help wikipedia expanding ithttpsenwikipediaorgwikidapagliflozinmetformin